Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
OTO Open|September 14, 2020
A Cure for PAINS? A Novel Approach to Management of Proton-Associated Internal Nasal Valve StenosisStephanie Flukes, Martin Hanson, Matthew Bott, et al.Virology|July 7, 2018
Induction of the unfolded protein response (UPR) during Marek's disease virus (MDV) infectionSabari Nath Neerukonda, Upendra K Katneni, Matthew Bott, et al.The Journal of Thoracic and Cardiovascular Surgery|November 25, 2010
Pericardial effusions in the cancer population: prognostic factors after pericardial window and the impact of paradoxical hemodynamic instabilityPatrick L Wagner, Eileen McAleer, Elizabeth Stillwell, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2012
New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessmentMarc Ladanyi, Marjorie G Zauderer, Lee M Krug, et al.Surgical Endoscopy|December 12, 2018
Does pyloric drainage have a role in the era of minimally invasive esophagectomy?Tamar Nobel, Kay See Tan, Arianna Barbetta, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2013
Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutationsMarjorie G Zauderer, Matthew Bott, Robert McMillan, et al.Seminars in Thoracic and Cardiovascular Surgery|January 14, 2021
Systematic Review of Neoadjuvant Immunotherapy for Patients With Non-Small Cell Lung CancerChristopher Cao, Allen Guo, Christopher Chen, et al.Clinical Chemistry and Laboratory Medicine|February 6, 2010
Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levelsAlex J Rai, Raja M Flores, Anu Mathew, et al.Current Oncology (Toronto, Ont.)|December 13, 2021
Meta-Analysis of Neoadjuvant Immunotherapy for Patients with Resectable Non-Small Cell Lung CancerChristopher Cao, Anthony Le, Matthew Bott, et al.The Journal of Thoracic and Cardiovascular Surgery|December 22, 2020
Predictors of survival following surgical resection of limited-stage small cell lung cancerNicolas Zhou, Matthew Bott, Bernard J Park, et al.Pageof 4